Skip to content

A Clinical Study To Assess The Effect Of Ayurveda Treatment Protocol In Patients With Hyperacidity (Amlapitta)

Efficacy Of Ayurveda Treatment Protocol Compared To Vonoprazan In Patients With Functional Dyspepsia (Amlapitta) A Randomized Controlled Trial - FD

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099579
Enrollment
60
Registered
2025-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

None listed

Sponsors

Dr Zanzad Vrushali Bhagwan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 18 and 60 Years. 2.Sex : Both sexes. 3.Patients with signs and symptoms of Functional Dyspepsia. 4.Patients with signs and symptoms of Amlapitta. 5.Patients who are willing to give written informed consent. 6.Those patients who are on existing FD treatment will be asked to undergo a 7 days wash out period. After this interval, they may be included in our study.

Exclusion criteria

Exclusion criteria: 1.Patients who are regularly consuming NSAIDs, low dose aspirin will be excluded. 2.Patients having History of bleeding disorders. 3.Known case of CA stomach and TB. 4.History(within 6months) or diagnosed case of H.pylori infection. 5.Patients with history of uncontrolled HTN/DM and other major systemic illness. 6.Pregnant women , lactating mother. 7.Those high risk patients who are having upper Gastrointenstinal pathology which require Upper GI Endoscopy for evaluation. 8.Patients suffering or having history of peptic ulcer, gastric or esophageal malignant disease or patient undergone gastrectomy.

Design outcomes

Primary

MeasureTime frame
SF-LDQ Criteria (Short form leeds dyspepsia questionarre)Timepoint: Baseline,14th day,28th day,42th day,56th day

Secondary

MeasureTime frame
1.Amlapitta symptom rating scale. 2.VAS scale analysis. Timepoint: Baseline,14th day,28th day,42th day,56th day;1.NDI (Nepean Dyspepsia Index) 2.GDSS (Glassgow Dyspepsia Severity Score) 3.AST (Aspartate Amino Transferase) 4.ALT (Alanine Amino Transferase) 5.Serum CreatinineTimepoint: Baseline, 28th day;HB% (Haemoglobin percentage)Timepoint: Baseline

Countries

India

Contacts

Public ContactDr R Sunil Kumar

KAHERs Shri BMK Ayurveda Mahavidyalaya Post Graduate Studies And Research Centre Shahapur Belagavi

dr.sunil.devaki@gmail.com8309545056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026